Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
Clinical trial NCT02168946 · COMPLETED
Trial details
- NCT number
- NCT02168946
- Sponsor
- Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2017-07-21
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.